If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Board Change

22 Jan 2018 07:00

RNS Number : 4590C
Accrol Group Holdings PLC
22 January 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

22 January 2018

Accrol Group Holdings plc("Accrol" or the "Company")Board Change

 

Accrol Group Holdings plc (AIM:ACRL) announces that James Flude has resigned as a director of Accrol with effect from 9 February 2018 and will leave the Company on that date to pursue other interests. In the intervening period, James will no longer be the Chief Financial Officer but will remain on the Board as an Executive Director.

 

The Board has commenced a search for a permanent replacement Chief Financial Officer. In the meantime, Martin Leitch will assume the role of interim Chief Financial Officer but will remain on the operational board.

 

Gareth Jenkins, Chief Executive Officer of Accrol, commented: "On behalf of the Board, I would like to thank James for the contribution that he has made to Accrol, in particular for his contribution under Private Equity ownership and, more recently, for the key role he played in the successful IPO. We wish him well for the future."

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

Today: +44 (0) 7715 769 078

Gareth Jenkins, Chief Executive Officer

Thereafter: +44 (0) 1254 278 844

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest wholesalers and retailers.

Accrol operates from three sites:

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

In addition, the business has a storage and distribution facility in Skelmersdale, Lancashire.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBMMTMBTTBMP
Date   Source Headline
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.